Deciphering Complex Lab Data With Machine Learning

07/26/2021 By Andrea

Authored and contributed to PharmaLeaders by Jason Bhan, MD Accurate analysis of healthcare data is critical for research, delivery of care, treatment variability, and improving patient outcomes. The ability to identify patterns in real-world data (RWD) demands insights with faster speeds, greater specificity, and improved accuracy. And the challenges are increasing as more healthcare data […]

The Roadmap to Real-Time Data Sharing in Clinical Trials

07/14/2021 By Andrea

Article authored and contributed to PharmaLeaders by Marc Leighton, VP of Product for Florence Healthcare With the rise of decentralized technology across the clinical trial industry, real-time data sharing has become critical. If research sites, local physicians, trial participants, CROs, and sponsors can’t instantly share data with one another, remote or hybrid clinical trials will […]

US FDA approves Samsung Bioepis and Biogen’s Byooviz

09/26/2021

The US Food and Drug Administration (FDA) has approved Samsung Bioepis and Biogen’s Byooviz (ranibizumab-nuna), a biosimilar referencing Lucentis (ranibizumab). Byooviz is an anti-vascular endothelial growth factor (VEGF) The post US FDA approves Samsung Bioepis and Biogen’s Byooviz appeared first … [Read More...]

Boehringer acquires Abexxa Biologics to develop novel cancer therapies

09/26/2021

German pharmaceutical firm Boehringer Ingelheim has acquired Abexxa Biologics to expand its research efforts in cancer immunology and novel immunotherapeutic approaches. The financial details of the transaction were The post Boehringer acquires Abexxa Biologics to develop novel cancer therapies … [Read More...]

Pfizer-BioNTech reports positive results for Covid-19 vaccine trail in children aged 5 to 11 years

09/25/2021

Pfizer and its partner BioNTech have announced positive topline results from a pivotal trial of their Covid-19 vaccine in children aged 5 to 11 years. The Phase II/III The post Pfizer-BioNTech reports positive results for Covid-19 vaccine trail in children aged 5 to 11 years appeared first on … [Read More...]

AstraZeneca partners with VaxEquity on self-amplifying RNA therapeutics

09/25/2021

AstraZeneca has entered a strategic, long-term research collaboration with biopharmaceutical firm VaxEquity to discover, develop and commercialise self-amplifying RNA (saRNA) therapeutics platform. VaxEquity was founded last year by The post AstraZeneca partners with VaxEquity on self-amplifying … [Read More...]

Featured Article

Deciphering Complex Lab Data With Machine Learning

The Roadmap to Real-Time Data Sharing in Clinical Trials

White Papers

Balancing Innovation and Risk Management in Biopharma Commercialization

Patient-Provider Dialogue

Industry News

US FDA approves Samsung Bioepis and Biogen’s Byooviz

Boehringer acquires Abexxa Biologics to develop novel cancer therapies

Pfizer-BioNTech reports positive results for Covid-19 vaccine trail in children aged 5 to 11 years

AstraZeneca partners with VaxEquity on self-amplifying RNA therapeutics